Repositioning of Non-Steroidal Anti Inflammatory Drug (NSAIDs) for Cancer Treatment: Promises and Challenges

Abstract

Cancer, a disease is still the second most common cause of death in the U.S. According to the report of American Cancer Society, more than 1,500 people die every day because of cancer [1]. Current treatments for various cancers therapies have improved patients’ survival rate but they suffer from several limitations [2]. For example, the non-specific distribution of drugs limits the therapeutic dose within cancer cells and thereby causing several adverse side effects including hair loss, weakness, and organ dysfunction, leading to a low quality of life for cancer patients [3].

Extracted Key Phrases

0204020162017
Citations per Year

Citation Velocity: 9

Averaging 9 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@inproceedings{Kumar2016RepositioningON, title={Repositioning of Non-Steroidal Anti Inflammatory Drug (NSAIDs) for Cancer Treatment: Promises and Challenges}, author={Raj Kumar}, year={2016} }